SCHEMBL2807960

SCHEMBL2807960

C#Cc1cc(N)ccc1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.52
CASP1 P29466 5/20 0.50
TSHR P16473 4/20 0.46
CYP3A4 P08684 3/20 0.46
PDE10A Q9Y233 1/20 0.41
PLA2G7 Q13093 1/20 0.41
KDM4E B2RXH2 6/20 0.41
LMNA P02545 4/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
RECQL P46063 1/20 0.39
USP2 O75604 1/20 0.38
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
THRB P10828 2/20 0.36
ALOX15 P16050 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ACHE P22303 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
NPC1 O15118 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL688670 0.78 ALDH1A1 (0.42) ALDH1A1CASP1TSHRCYP3A4KDM4E
SCHEMBL29642345 0.78 ALDH1A1 (0.42) ALDH1A1CASP1TSHRCYP3A4KDM4E
SCHEMBL31184930 0.77 ALDH1A1 (0.57) ALDH1A1CASP1TSHRCYP3A4PDE10A
SCHEMBL17653959 0.77 ALDH1A1 (0.52) ALDH1A1CASP1TSHRCYP3A4PDE10A
SCHEMBL61459 0.77 ALDH1A1 (0.57) ALDH1A1CASP1TSHRCYP3A4PDE10A
SCHEMBL18992027 0.77 ALDH1A1 (0.52) ALDH1A1CASP1TSHRCYP3A4PDE10A
SCHEMBL2808490 0.77 ALDH1A1 (0.52) ALDH1A1CASP1TSHRCYP3A4PDE10A
SCHEMBL9815925 0.76 TSHR (0.38) ALDH1A1CASP1TSHRCYP3A4PLA2G7
SCHEMBL16178467 0.76 PTPN1 (0.42) ALDH1A1CASP1TSHRCYP3A4KDM4E
SCHEMBL3220960 0.76 TDP1 (0.42) ALDH1A1CYP3A4KDM4ELMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118259012-A Method for global analysis of functional histidines in proteins 深圳湾实验室 2024-06-28 CN claimed
CN-118259012-A Method for global analysis of functional histidines in proteins 深圳湾实验室 2024-06-28 CN disclosed
EP-3246327-B1 3-ACETYLENYL-PYRAZOLE-PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USES THEREOF SI CHUAN UNIV (CN) 2022-11-23 EP disclosed
EP-3628103-A1 NONAQUEOUS ELECTROLYTE, NONAQUEOUS ELECTROLYTE ENERGY STORAGE DEVICE, AND METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE ENERGY STORAGE DEVICE Robert Bosch GmbH (DE) 2020-04-01 EP disclosed
US-10266537-B2 3-acetylenyl-pyrazole-pyrimidine derivative, and preparation method therefor and uses thereof St. Chuan University (CN) 2019-04-23 US disclosed
US-10266537-B2 3-acetylenyl-pyrazole-pyrimidine derivative, and preparation method therefor and uses thereof St. Chuan University (CN) 2019-04-23 US disclosed
CN-106800654-B A method of polybenzoxazoles is prepared based on backbone chain type benzoxazine 江苏大学 2019-02-05 CN disclosed
CN-105837575-B 3- acetenyl Pyrazolopyrimidine derivative and its preparation method and application 四川大学 2019-01-15 CN disclosed
WO-2018224286-A1 NONAQUEOUS ELECTROLYTE, NONAQUEOUS ELECTROLYTE ENERGY STORAGE DEVICE, AND METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE ENERGY STORAGE DEVICE Lithium Energy and Power GmbH & Co. KG (DE) 2018-12-13 WO disclosed
EP-3246327-A1 3-ACETYLENYL-PYRAZOLE-PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USES THEREOF Si Chuan University (CN) 2017-11-22 EP disclosed
US-20100048543-A1 PYRIMIDINE COMPOUNDS HAVING TIES (TEK) INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2010-02-25 US disclosed
US-20080194552-A1 Aminopyrimidine Derivatives With Tie2 Inhibiting Activity ASTRAZENECA AB (SE) 2008-08-14 US disclosed
US-20080194552-A1 Aminopyrimidine Derivatives With Tie2 Inhibiting Activity ASTRAZENECA AB (SE) 2008-08-14 US disclosed
US-20080194552-A1 Aminopyrimidine Derivatives With Tie2 Inhibiting Activity ASTRAZENECA AB (SE) 2008-08-14 US disclosed
CN-101198602-A Saminopyrimidine derivates with tIE2 inhibiting activity ASTRAZENECA AB (SE) 2008-06-11 CN disclosed
EP-1893605-A2 SAMINOPYRIMIDINE DERIVATES WITH TIE2 INHIBITING ACTIVITY AstraZeneca AB (SE) 2008-03-05 EP disclosed
CN-101137652-A Pyrimidine compounds having tie2 (tek) inhibitory activity ASTRAZENECA AB (SE) 2008-03-05 CN disclosed
EP-1863805-A1 PYRIMIDINE COMPOUNDS HAVING TIE2 (TEK) INHIBITORY ACTIVITY AstraZeneca AB (SE) 2007-12-12 EP disclosed
WO-2006103449-A2 SAMINOPYRIMIDINE DERIVATES WITH TIE2 INHIBITING ACTIVITY ASTRAZENECA AB (SE) 2006-10-05 WO disclosed
WO-2006082373-A1 PYRIMIDINE COMPOUNDS HAVING TIES (TEK) INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2006-08-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10266537-B2 3-acetylenyl-pyrazole-pyrimidine derivative, and preparation method therefor and uses thereof DPYD, TYMP, WEE1 ALDH1A1 78/4885CASP1 1181/4885TSHR 4320/4885
US-20080194552-A1 Aminopyrimidine Derivatives With Tie2 Inhibiting Activity TIE1, TEK, FLT1 ALDH1A1 1756/4885CASP1 3497/4885TSHR 3638/4885
US-20100048543-A1 PYRIMIDINE COMPOUNDS HAVING TIES (TEK) INHIBITORY ACTIVITY TEK, TYMP, TIE1 ALDH1A1 2198/4885CASP1 3734/4885TSHR 2425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.